Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Precision Biosciences (DTIL) Loans and Notes Receivables (2023 - 2024)

Precision Biosciences (DTIL) has disclosed Loans and Notes Receivables for 2 consecutive years, with $12.3 million as the latest value for Q2 2024.

  • Quarterly Loans and Notes Receivables changed N/A to $12.3 million in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $12.3 million through Jun 2024, changed N/A year-over-year, with the annual reading at $11.9 million for FY2023, N/A changed from the prior year.
  • Loans and Notes Receivables for Q2 2024 was $12.3 million at Precision Biosciences, up from $11.6 million in the prior quarter.
  • The five-year high for Loans and Notes Receivables was $12.3 million in Q2 2024, with the low at $11.6 million in Q1 2024.